)

Saurabh Paliwal
Saurabh Paliwal, is a seasoned scientific leader with over 20 years of experience in biopharma R&D, driving innovation in drug discovery, translational research, and precision medicine. Their expertise spans oncology, immunology, cardiovascular, and neuroscience therapeutic areas, as well as multiple modalities including small molecules, biologics, and cell & gene therapies. They have pioneered the development and application of advanced technologies—from multi-omics (genomics, single-cell, spatial, proteomics, epigenomics) and functional genomics (CRISPR screening/editing) to high-content screening, targeted delivery, and IND-enabling assay development. Known for building and leading high-performing teams, [Name] excels at cross-functional collaboration with scientific, business, and external partners. With a proven track record in both startups (Sana Biotechnology, Genapsys, Euveda Biosciences) and large pharma (Bristol Myers Squibb), Saurabh is passionate about leveraging cutting-edge science to accelerate therapeutic innovation and improve patient outcomes.